Antimicrobial textiles are becoming another weapon in the arsenal against HAIs, with the recognition that soft surfaces in the healthcare environment can become contaminated and possibly spread disease-causing pathogens. Infection Control Today invited clinical representatives from two leading manufacturers of antimicrobial textiles to provide information that can help infection preventionists better evaluate products constructed from these fabrics. Our experts are Peggy Prinz Leubbert, MS, MT (ASCP), CIC, CHSP, founder and owner of Healthcare Interventions, Inc. in Omaha, Neb.; and Thomas M. Claffey, MD, director of the Infectious Diseases Division at Maine Medical Center and an epidemiologist at Mercy Hospital in Portland, Maine.
Vet IP Roundtable 2: Infection Control and Biosecurity Challenges in Veterinary Care
March 31st 2025Veterinary IPs highlight critical gaps in cleaning protocols, training, and biosecurity, stressing the urgent need for standardized, animal-specific infection prevention practices across diverse care settings.
Invisible, Indispensable: The Vital Role of AHRQ in Infection Prevention
March 25th 2025With health care systems under strain and infection preventionists being laid off nationwide, a little-known federal agency stands as a last line of defense against preventable patient harm. Yet the Agency for Healthcare Research and Quality (AHRQ) is now facing devastating cuts—threatening decades of progress in patient safety.
Unraveling a Candida auris Outbreak: Infection Control Challenges in a Burn ICU
March 19th 2025A Candida auris outbreak in a burn intensive care unit (BICU) in Illinois has highlighted the persistent challenges of infection control in high-risk health care settings. Despite rigorous containment efforts, this multidrug-resistant fungal pathogen continued to spread, underscoring the need for enhanced prevention strategies, environmental monitoring, and genomic surveillance.
Unmasking Long COVID: Dr Noah Greenspan on Recovery, Research Gaps, and the Future of Treatment
March 18th 2025Dr Noah Greenspan discusses the evolving understanding of long COVID, current treatment strategies, diagnostic challenges, and the critical need for research and awareness in post-viral syndromes.